News
Chinese Clinical Oncology is now indexed by PubMed/MEDLINE: a big step forward
Chinese Clinical Oncology
2015;
4
(1)
:1
.
(30 March 2015)
Preface
Lymphoma: looking from the present to the future
Chinese Clinical Oncology
2015;
4
(1)
:2
.
(30 March 2015)
Review Article
Pitfalls in the pathological diagnosis of lymphoma
Chinese Clinical Oncology
2015;
4
(1)
:3
.
(30 March 2015)
PET/CT: appropriate application in lymphoma
Chinese Clinical Oncology
2015;
4
(1)
:4
.
(30 March 2015)
Staging and response assessment in lymphomas: the new Lugano classification
Chinese Clinical Oncology
2015;
4
(1)
:5
.
(30 March 2015)
Radiotherapy in early stage classical Hodgkin lymphoma: past, present and future
Chinese Clinical Oncology
2015;
4
(1)
:6
.
(30 March 2015)
Individualized management of follicular lymphoma
Chinese Clinical Oncology
2015;
4
(1)
:7
.
(30 March 2015)
Mantle cell lymphoma-management in evolution
Chinese Clinical Oncology
2015;
4
(1)
:8
.
(30 March 2015)
Double hit diffuse large B-cell lymphomas: diagnostic and therapeutic challenges
Chinese Clinical Oncology
2015;
4
(1)
:9
.
(30 March 2015)
Primary extranodal B-cell lymphoma: current concepts and treatment strategies
Chinese Clinical Oncology
2015;
4
(1)
:10
.
(30 March 2015)
New approaches in primary central nervous system lymphoma
Chinese Clinical Oncology
2015;
4
(1)
:11
.
(30 March 2015)
Extranodal natural killer/T cell lymphoma: we should and we can do more
Chinese Clinical Oncology
2015;
4
(1)
:12
.
(30 March 2015)
Risk- and response-adapted strategies for the management of Hodgkin lymphoma
Chinese Clinical Oncology
2015;
4
(1)
:13
.
(30 March 2015)
New drugs for the treatment of non-Hodgkin lymphomas
Chinese Clinical Oncology
2015;
4
(1)
:14
.
(30 March 2015)
Meet the Professor
Professor Shukui Qin: patient reported outcomes in study of axitinib or sorafenib in Asian patients with metastatic renal cell carcinoma
Chinese Clinical Oncology
2015;
4
(1)
:15
.
(30 March 2015)
Professor Jon Wigginton: where we are standing in immunotherapy
Chinese Clinical Oncology
2015;
4
(1)
:16
.
(30 March 2015)
Disclosure:
The focused issue “Lymphoma” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding. Bruce D. Cheson and Jun Zhu served as the unpaid Guest Editors for the focused issue.
